Pregnancy is full of unknowns. As much as we try to plan, prepare, and stay positive, the truth is that a lot can happen — and not all of it is within our control.

Take it from me: my journey to and through motherhood has been anything but straightforward. I’ve experienced preterm labor, bed rest, and the constant anxiety that comes with navigating a complicated pregnancy. And my co-founder, Abby, nearly lost her life to preeclampsia while pregnant with her twins. Those experiences, quite frankly, shook us to our core — and made us realize just how important the need is for better tools in prenatal care.

That’s why, when we learned about Encompass™, a simple at-home blood test that can predict your risk of developing preeclampsia months before symptoms appear, our first thought was: why isn’t this already the standard of care?

What is preeclampsia, and why should you care?

Preeclampsia is a common but serious pregnancy complication that impacts 1 in 12 pregnancies. It can seem to strike out of nowhere, even in pregnancies that appear otherwise healthy. Characterized by high blood pressure and signs of organ damage, preeclampsia can progress quickly, leading to seizures, preterm birth, and even life-threatening complications for both mom and baby.

It's one of the leading causes of NICU stays and long-term health challenges — yet, for decades, the medical approach to managing it has basically been… wait and see. Not ideal when you’re trying to stay ahead of potential complications to create the healthiest pregnancy possible.

Traditionally, doctors check for preeclampsia by measuring blood pressure and urine for protein at prenatal appointments. But here's the catch: by the time those signs show up, preeclampsia has already developed. You’re already in it.

default alt text

The trouble with “general” risk factors

Because early risk assessment hasn’t been possible (until now), the medical community has relied on broad, generalized guidelines to assess preeclampsia risk. Think: age, race, weight, or use of IVF

But this one-size-fits-all approach hasn’t been enough. Most pregnancies are categorized as having some level of risk for preeclampsia, but that label is so broad that it doesn’t help people take meaningful action. Not to mention, when risk feels abstract or impersonal, many of us don’t follow through with preventive steps like daily aspirin, lifestyle changes, or at-home monitoring. It’s human nature.

The result? Preeclampsia rates are still rising, and too many families are blindsided, just like Abby’s was.

Enter Encompass™: Next-generation pregnancy care

What makes Encompass™ such a game-changer is that it takes the guesswork out of assessing your risk for preeclampsia. It’s not about generalized statistics — it’s about the biology of your developing pregnancy.

Encompass™ combines a breakthrough blood test to predict your personal preeclampsia risk with a preventive action plan and a responsive virtual assistant to give you individualized support for the healthiest pregnancy possible.

Here’s how it works:

At-home blood test (that comes to you!)

Between 18–22 weeks of pregnancy, a mobile phlebotomist comes to your home and collects a simple blood sample. That’s it. No waiting rooms, no labs, no stress.

Breakthrough RNA science

The blood test analyzes thousands of RNA signals from you, your baby, and your placenta. Yes, it’s science-y — but it’s also kind of magical. This is cutting-edge research made actionable. By decoding these biological “messages,” Encompass can predict your personal risk for preeclampsia, not some generalized model that may or may not apply to you.

Secure, easy-to-understand results

In 10–14 days, your results are delivered to you (and your provider if you choose) via a secure online portal.

Evidence-based preventive action plan

Based on your results, you’ll get a tailored, evidence-backed plan that could include lifestyle changes, medication, or increased monitoring — all aimed at reducing your risk and supporting a healthier pregnancy.

Virtual assistant support

You also get access to a virtual assistant that provides personalized alerts, reminders, and guidance throughout your pregnancy, so you never feel like you’re navigating this alone.

default alt text

Who should consider Encompass?

If you’re currently pregnant and under 22 weeks along, and 35 or older, Encompass may be for you. You don’t need to have a history of complications to benefit — in fact, that’s the point. Preeclampsia doesn’t always come with a warning label, and this test helps you get ahead of it.

You can check your eligibility easily at encompasstest.com.

Backed by research, built with heart

Encompass is developed by Mirvie, a company that has been quietly but powerfully transforming the science of pregnancy complications for the last seven years. Their research, which began at Stanford University, is the largest of its kind, examining the molecular health of nearly 11,000 pregnancies. The team’s work is highly regarded in the medical community, and they’re now making this powerful technology available directly to expecting families through a self-pay option.

And while they’re also working toward insurance coverage in the future, they understand the urgency. Families shouldn’t have to wait years for better care — especially when the cost of complications can far exceed the cost of proactive testing. In a world where pregnancy and fertility care is becoming more expensive, investing in the right tools early on can actually help prevent the emotional and financial toll of complications later.

Why we’re sharing this

Because I’ve been there. Because Abby has been there. Because so many of us have faced unexpected complications in pregnancy and thought, Why didn’t I know?

Preeclampsia is sometimes unpredictable, but with Encompass, it doesn’t have to blindside you. We finally have the tools to get ahead of it — to feel empowered, not just reactive.

Pregnancy will always come with unknowns. But this? This is clarity. This is hope. And this, in my opinion, is a must-have for every pregnancy.

Let’s make sure no mom has to say, “I wish I had known.”

Let’s choose knowledge. Let’s choose action. Let’s choose health.

Let’s make this the new must-have in pregnancy care.

Want to learn more or see if you’re eligible for Encompass™? Visit encompasstest.com and use code: RESCRIPTED200 for $200 Off 


Kristyn Hodgdon is a passionate women's health advocate and the Co-Founder and Chief Creative Officer of Rescripted, where she helps break down complicated medical info into content that's easy to understand — and actually helpful. As an IVF mom who’s experienced pregnancy loss and lives with PCOS, Kristyn blends her professional know-how with real-life experience to support others navigating similar journeys. Her work has been featured on Good Morning America, ScaryMommy, and more, and she’s the host of the podcast From First Period To Last Period. A Fordham University grad, Kristyn also volunteers with the Fly Again Foundation, which supports breast cancer patients. You can find her on Instagram or connect with her on Linkedin.